• 1
    Restellini S, Kherad O, Jairath V, Martel M, Barkun AN. Red blood cell transfusion is associated with increased rebleeding in patients with nonvariceal upper gastrointestinal bleeding. Aliment Pharmacol Ther 2013; 37: 31622.
  • 2
    Barkun AN, Bardou M, Kuipers EJ, et al. International Consensus Recomendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010; 152: 10113.
  • 3
    Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol 2012; 107: 34560.
  • 4
    Elmunzer BJ, Young SD, Inadomi JM, Schoenfeld P, Laine L. Systemic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol 2008; 103: 262532.
    Direct Link:
  • 5
    Blatchford O, Murray WR, Blatchfod M. A risk score to predice need for treatment for upper gastrointestinal haemorrhage. Lancet 2000; 356: 131821.
  • 6
    Stanley AJ, Dalton HR, Blatchford O, et al. Multicentre comparison of the Glasgow Blatchford and Rockall scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage. Aliment Pharmacol Ther 2011; 34: 4705.
  • 7
    Rockall TA, Logan RFA, Devlin HB, Northfield TC; The steering committee and members of the National audit of acute upper gastrointestinal haemorrhage. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 31621.